The Relation Between BSS Solution Temperature and Endothelial Cells and Post Phaco Discomfort
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: phacoemulsification.
- Who it may be relevant to
- Registry conditions: Corneal Diseases. Basic parameters: 40 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
patients underwent phacoemulsification , balanced saline solution used during the operation will be at room temperature in one group and cool 2.7 c in the other group. the patients will be followed for 3 months after phacoemulsification regarding corneal endothelial cells and anterior segment inflammatory signs
Detailed description
patients underwent phacoemulsification , balanced saline solution used during the operation will be at room temperature in one group and cool 2.7 c in the other group. the patients will be followed for 3 months after phacoemulsification regarding corneal endothelial cells and anterior segment inflammatory signs
Interventions
- Other phacoemulsification
one group with BSS at room temperature and the other group with cold BSS
Primary outcome measures
- endothelial cell count [Time frame: 3 months]
Secondary outcome measures (1)
- incidence of anterior segment inflammation [Time frame: 3 months]
Eligibility criteria
Inclusion criteria
- patients with cataract
- more than 40 years
- no glaucoma
- no retinal abnormalities
- no retinal abnormalities
Exclusion criteria
patients with corneal diseases patients less than 40 patients with previous eye surgery
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Triple blind
- Primary purpose
- Other
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06904560 · sohag-med-25-1-5PD